In vivo imaging of enhanced leukocyte accumulation in atherosclerotic lesions in humans

Journal of the American College of Cardiology

Volumn 64, Issue 10, 2014, Pages 1019-1029

  Van Der Valk, Fleur M ^a   Kroon, Jeffrey ^b   Potters, Wouter V ^a   Thurlings, Rogier M ^a   Bennink, Roelof J ^a   Verberne, Hein J ^a   Nederveen, Aart J ^a   Nieuwdorp, Max ^a   Mulder, Willem J M ^a,c   Fayad, Zahi A ^c   Van Buul, Jaap D ^b   Stroes, Erik S G ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b SANQUIN RESEARCH   (Netherlands)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Atherosclerosis; Imaging; Inflammation; Peripheral blood mononuclear cells

Indexed keywords

FLUORODEOXYGLUCOSE F 18; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; DIAGNOSTIC AGENT;

ADULT; ARTERIAL WALL INFLAMMATION; ARTERIAL WALL TO BLOOD RATIO; ARTERY DIAMETER; ARTERY DISEASE; ARTICLE; ATHEROGENESIS; BLOOD VESSEL PARAMETERS; CARDIOVASCULAR DISEASE; CAROTID ATHEROSCLEROSIS; CELL TRACKING; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; IMAGE ANALYSIS; IN VIVO STUDY; ISOTOPE LABELING; LEUKOCYTE ACCUMULATION; LEUKOCYTE FUNCTION; LEUKOCYTE MIGRATION; MALE; NON INVASIVE PROCEDURE; NUCLEAR MAGNETIC RESONANCE IMAGING; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; ATHEROSCLEROSIS; AUTOTRANSPLANTATION; BLOOD; CASE CONTROL STUDY; CELL MOTION; COMPUTER ASSISTED TOMOGRAPHY; CONFIDENCE INTERVAL; CORONARY ARTERY DISEASE; IMAGING; INFLAMMATION; METHODOLOGY; MIDDLE AGED; MONONUCLEAR CELL; MULTIMODAL IMAGING; NONPARAMETRIC TEST; OBSERVER VARIATION; PERIPHERAL BLOOD MONONUCLEAR CELLS; PHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TRANSPLANTATION;

ATHEROSCLEROSIS; IMAGING; INFLAMMATION; PERIPHERAL BLOOD MONONUCLEAR CELLS;

CASE-CONTROL STUDIES; CELL MOVEMENT; CONFIDENCE INTERVALS; CORONARY ARTERY DISEASE; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; MULTIMODAL IMAGING; OBSERVER VARIATION; POSITRON-EMISSION TOMOGRAPHY; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED; TRANSPLANTATION, AUTOLOGOUS;

EID: 84908203020     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2014.06.1171     Document Type: Article

References (45)

1. Nahrendorf M, Swirski FK. Monocyte and macrophage heterogeneity in the heart. Circ Res 2013;112:1624-33.
2. Weber C, Zernecke A, Libby P. The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models. Nat Rev Immunol 2008;8:802-15.
3. Galkina E, Ley K. Vascular adhesion molecules in atherosclerosis. Arterioscler Thromb Vasc Biol 2007;27:2292-301.
4. Ley K, Miller YI, Hedrick CC. Monocyte and macrophage dynamics during atherogenesis. Arterioscler Thromb Vasc Biol 2011;31:1506-16.
5. Dutta P, Courties G, Wei Y, et al. Myocardial infarction accelerates atherosclerosis. Nature 2012;487:325-9.
6. Leuschner F, Dutta P, Gorbatov R, et al. Therapeutic siRNA silencing in inflammatory monocytes in mice. Nat Biotechnol 2011;29: 1005-10.
7. Okamoto M, Fuchigami M, Suzuki T, Watanabe N. A novel C-C chemokine receptor 2 antagonist prevents progression of albuminuria and atherosclerosis in mouse models. Biol Pharm Bull 2012;35:2069-74.
8. Peters W, Charo IF. Involvement of chemokine receptor 2 and its ligand, monocyte chemoattractant protein-1, in the development of atherosclerosis: lessons from knockout mice. Curr Opin Lipidol 2001;12:175-80.
9. Potteaux S, Gautier EL, Hutchison SB, et al. Suppressed monocyte recruitment drives macrophage removal from atherosclerotic plaques of Apoe-/-mice during disease regression. J Clin Invest 2011;121:2025-36.
10. Hansson GK, Hermansson A. The immune system in atherosclerosis. Nat Immunol 2011;12: 204-12.
11. Zhou X, Robertson AK, Rudling M, Parini P, Hansson GK. Lesion development and response to immunization reveal a complex role for CD4 in atherosclerosis. Circ Res 2005;96:427-34.
12. Sabatine MS, Morrow DA, Cannon CP, et al. Relationship between baseline white blood cell count and degree of coronary artery disease and mortality in patients with acute coronary syndromes: a TACTICS-TIMI 18 (Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy-Thrombolysis in Myocardial Infarction 18 trial) substudy. J Am Coll Cardiol 2002;40:1761-8.
13. Rogacev KS, Cremers B, Zawada AM, et al. CD14++CD16+ monocytes independently predict cardiovascular events: a cohort study of 951 patients referred for elective coronary angiography. J Am Coll Cardiol 2012;60:1512-5.
14. Bekkering S, Joosten LA, van der Meer JW, Netea MG, Riksen NP. Trained innate immunity and atherosclerosis. Curr Opin Lipidol 2013;24: 487-92.
15. Stenvinkel P, Karimi M, Johansson S, et al. Impact of inflammation on epigenetic DNA methylation-a novel risk factor for cardiovascular disease? J Intern Med 2007;261:488-99.
16. Wierda RJ, Geutskens SB, Jukema JW, Quax PH, van den Elsen PJ. Epigenetics in atherosclerosis and inflammation. J Cell Mol Med 2010;14:1225-40.
17. Wu C, Li F, Niu G, Chen X. PET imaging of inflammation biomarkers. Theranostics 2013;3: 448-66.
18. Trivedi RA, Mallawarachi C, King-Im JM, et al. Identifying inflamed carotid plaques using in vivo USPIO-enhanced MR imaging to label plaque macrophages. Arterioscler Thromb Vasc Biol 2006;26:1601-6.
19. Herenius MM, Thurlings RM, Wijbrandts CA, et al. Monocyte migration to the synovium in rheumatoid arthritis patients treated with adalimumab. Ann Rheum Dis 2011;70:1160-2.
20. van Hemert FJ, Thurlings R, Dohmen SE, et al. Labeling of autologous monocytes with 99mTc-HMPAO at very high specific radioactivity. Nucl Med Biol 2007;34:933-8.
21. van RJ, Kroon J, Hoogenboezem M, et al. The Rho-guanine nucleotide exchange factor Trio controls leukocyte transendothelial migration by promoting docking structure formation. Mol Biol Cell 2012;23:2831-44.
22. Abeles RD, McPhail MJ, Sowter D, et al. CD14, CD16 and HLA-DR reliably identifies human monocytes and their subsets in the context of pathologically reduced HLA-DR expression by CD14(hi)/CD16(neg) monocytes: Expansion of CD14(hi)/CD16(pos) and contraction of CD14(lo)/ CD16(pos) monocytes in acute liver failure. Cytometry A 2012;81:823-34.
23. Gower RM, Wu H, Foster GA, et al. CD11c/ CD18 expression is upregulated on blood monocytes during hypertriglyceridemia and enhances adhesion to vascular cell adhesion molecule-1. Arterioscler Thromb Vasc Biol 2011; 31:160-6.
24. Rudd JH, Myers KS, Bansilal S, et al. (18)Fluorodeoxyglucose positron emission tomography imaging of atherosclerotic plaque inflammation is highly reproducible: implications for atherosclerosis therapy trials. J Am Coll Cardiol 2007;50: 892-6.
25. Duivenvoorden R, de GE, Elsen BM, et al. In vivo quantification of carotid artery wall dimensions: 3.0-Tesla MRI versus B-mode ultrasound imaging. Circ Cardiovasc Imaging 2009;2: 235-42.
26. Rudd JH, Myers KS, Bansilal S, et al. Relationships among regional arterial inflammation, calcification, risk factors, and biomarkers: a prospective fluorodeoxyglucose positron-emission tomography/computed tomography imaging study. Circ Cardiovasc Imaging 2009;2:107-15.
27. Ye YX, Basse-Lusebrink TC, Arias-Loza PA, et al. Monitoring of monocyte recruitment in reperfused myocardial infarction with intramyocardial hemorrhage and microvascular obstruction by combined fluorine 19 and proton cardiac magnetic resonance imaging. Circulation 2013;128:1878-88.
28. Kircher MF, Grimm J, Swirski FK, et al. Noninvasive in vivo imaging of monocyte trafficking to atherosclerotic lesions. Circulation 2008;117:388-95.
29. Swirski FK, Pittet MJ, Kircher MF, et al. Monocyte accumulation in mouse atherogenesis is progressive and proportional to extent of disease. Proc Natl Acad Sci U S A 2006;103:10340-5.
30. Galkina E, Ley K. Leukocyte influx in atherosclerosis. Curr Drug Targets 2007;8:1239-48.
31. Yona S, Kim KW, Wolf Y, et al. Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis. Immunity 2013;38:79-91.
32. Libby P, Ridker PM, Hansson GK. Progress and challenges in translating the biology of atherosclerosis. Nature 2011;473:317-25.
33. Stoneman V, Braganza D, Figg N, et al. Monocyte/macrophage suppression in CD11b diphtheria toxin receptor transgenic mice differentially affects atherogenesis and established plaques. Circ Res 2007;100:884-93.
34. Robbins CS, Hilgendorf I, Weber GF, et al. Local proliferation dominates lesional macrophage accumulation in atherosclerosis. Nat Med 2013;19: 1166-72.
35. Yla-Herttuala S, Bentzon JF, Daemen M, et al. Stabilization of atherosclerotic plaques: an update. Eur Heart J 2013;34:3251-8.
36. Kataoka Y, Shao M, Wolski K, et al. Myeloperoxidase levels predict accelerated progression of coronary atherosclerosis in diabetic patients: Insights from intravascular ultrasound. Atherosclerosis 2014;232:377-83.
37. Marnane M, Merwick A, Sheehan OC, et al. Carotid plaque inflammation on 18F-fluorodeoxyglucose positron emission tomography predicts early stroke recurrence. Ann Neurol 2012;71: 709-18.
38. Menezes LJ, Kotze CW, Agu O, et al. Investigating vulnerable atheroma using combined (18)F-FDG PET/CT angiography of carotid plaque with immunohistochemical validation. J Nucl Med 2011;52:1698-703.
39. Ridker PM, MacFadyen J, Libby P, Glynn RJ. Relation of baseline high-sensitivity C-reactive protein level to cardiovascular outcomes with rosuvastatin in the Justification for Use of statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER). Am J Cardiol 2010;106: 204-9.
40. Mosig S, Rennert K, Krause S, et al. Different functions of monocyte subsets in familial hypercholesterolemia: potential function of CD14+ CD16+ monocytes in detoxification of oxidized LDL. FASEB J 2009;23:866-74.
41. Cybulsky MI, Iiyama K, Li H, et al. A major role for VCAM-1, but not ICAM-1, in early atherosclerosis. J Clin Invest 2001;107:1255-62.
42. Combadiere C, Potteaux S, Rodero M, et al. Combined inhibition of CCL2, CX3CR1, and CCR5 abrogates Ly6C(hi) and Ly6C(lo) monocytosis and almost abolishes atherosclerosis in hypercholesterolemic mice. Circulation 2008;117: 1649-57.
43. Tardif JC, McMurray JJ, Klug E, et al. Effects of succinobucol (AGI-1067) after an acute coronary syndrome: a randomised, doubleblind, placebo-controlled trial. Lancet 2008;371: 1761-8.
44. Kalinowska A, Losy J. Investigational C-C chemokine receptor 2 antagonists for the treatment of autoimmune diseases. Expert Opin Investig Drugs 2008;17:1267-79.
45. Weber C, Noels H. Atherosclerosis: current pathogenesis and therapeutic options. Nat Med 2011;17:1410-22.